Treatment of viral hepatitis C genotypes 1 and 2 by sofosbuvir and ledipasvir with or without ribavirin combination: A possible alternative to pangenotypic treatment in a low-income country?-Reference-Cited by-同舟云学术

Treatment of viral hepatitis C genotypes 1 and 2 by sofosbuvir and ledipasvir with or without ribavirin combination: A possible alternative to pangenotypic treatment in a low-income country?

Published:2021-06 Issue: Volume:107 Page:166-169
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Razafindrazoto Chantelli Iamblaudiot^ORCID,Rasolonjatovo Anjaramalala Sitraka,Rabenjanahary Tovo Harimanana,Randriamifidy Nitah Harivony,Rakotozafindrabe Andry Lalaina Rinà,Razafimahefa Soloniaina Hélio,Ramanampamonjy Rado Manitrala

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Disease-Infectious Disease Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection;AASLD-IDSA Hepatitis C Guidance Panel;Hepatology,2020

2. High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C;Abozeid;Int J Infect Dis,2018

3. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014

4. Ledipasvir―sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection;Asahina;Liver Int,2018

5. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS);Bourliere;Lancet Infect Dis,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Advances in Electrochemical Synthesis of Spirocyclic Skeleton Compounds;Synthesis;2023-01-24